Cigna · Glp 1 T 2d · US health-plan appeal rights

Glp 1 T 2d denied for failing step therapy by Cigna?

Q: How long do I have to appeal a Cigna Glp 1 T 2d denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Cigna typically requires

Cigna's specific coverage criteria for glp1 t2d are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: Cigna / Express Scripts GLP-1 RA Prior Authorization — Type 2 Diabetes

The Cigna angle on Glp 1 T 2d

## Why Cigna Requires Step Therapy for Your GLP-1 Medication — and How to Appeal

Cigna's step-therapy (also called "fail-first") requirement means the plan will not cover a GLP-1 receptor agonist for type 2 diabetes until you have documented a trial of one or more "preferred" medications — typically older, lower-cost agents in the diabetes drug class. The denial is not a judgment that GLP-1 therapy is wrong for you; it is an administrative gate. It becomes appealable the moment you can show either (a) you already tried the required prior agents and they were inadequate or caused harm, or (b) your clinical circumstances make the required prior step medically contraindicated or otherwise inappropriate.

## Federal Appeal Rights

ACA §2719 / External Review: Non-grandfathered plans must offer independent external review after internal appeals are exhausted. You have approximately four months from the final internal denial to request external review. An expedited pathway (decision within 72 hours) is available when delay would seriously jeopardize your health.
ERISA §503: Employer self-funded plans fall under ERISA's full-and-fair review standard. Cigna must disclose the exact criteria used and allow you to submit medical evidence.
State step-therapy laws: Many states have enacted step-therapy override laws requiring insurers to grant exceptions when a prescriber certifies the standard sequence is not clinically appropriate. Confirm whether your state's law applies to your plan type.

## Appeal Process and Timeline

1. Pull the denial letter — it must state which step(s) Cigna required and why the claim failed. 2. File a Level 1 internal appeal within the deadline shown on your Explanation of Benefits (typically 180 days). 3. If the internal appeal is denied, request external review within the four-month federal window. 4. For expedited external review, your prescriber must document that waiting for standard timelines would harm your health.

## Documentation to Gather

Prior treatment history: Chart entries, pharmacy records, or prescriber notes showing every prior diabetes medication tried, the dates of each trial, and the documented outcome (inadequate glycemic control, side effect, contraindication).
Diagnosis and severity confirmation: Current clinical notes, recent lab values establishing metabolic status, and documentation of any comorbidities that make the requested agent the appropriate choice.
Prescriber medical-necessity letter: Your physician should explain why the GLP-1 agent is required at this point in the treatment sequence, citing the FDA-approved prescribing label and the applicable ADA or specialty guideline — without relying on specific numbers, but connecting your documented clinical picture to the labeled indications.
Step-therapy exception request: If your state or plan has a formal exception process, file it simultaneously with the internal appeal.

## Criteria-Mapping Strategy

Download Cigna's current coverage/clinical policy for this GLP-1 agent and list every step-therapy prerequisite it names. For each required prior step, document in the appeal letter: the agent name, the trial dates, and the specific reason it was discontinued or deemed insufficient. If a required step was never taken, explain why your prescriber judged it clinically inappropriate and tie that reasoning to the FDA label and guideline language. External reviewers look for a clear, evidence-supported narrative that the required sequence was either completed or genuinely not appropriate for this patient.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Cigna appeals

Other denial reasons for Cigna Glp 1 T 2d

denied as not medically necessary denied as non-formulary denied for missing prior authorization denied as experimental or investigational denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.